An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 022320
Company: GALDERMA LABS LP

Summary Review

Products on NDA 022320

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
EPIDUO	ADAPALENE; BENZOYL PEROXIDE	0.1%;2.5%	GEL;TOPICAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 022320

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/08/2008	ORIG-1	Approval	Type 4 - New Combination	STANDARD	Label (PDF) Letter (PDF) Review Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022320lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022320s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022320_epiduo_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022320s000_SumR.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
08/01/2014	SUPPL-8	Manufacturing (CMC)		Label is not available on this site.
07/01/2014	SUPPL-7	Manufacturing (CMC)		Label is not available on this site.
02/15/2013	SUPPL-5	Manufacturing (CMC)		Label is not available on this site.
02/01/2013	SUPPL-4	Efficacy-New Patient Population	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022320s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022320Orig1s004ltr.pdf
12/14/2011	SUPPL-2	Labeling	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022320s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022320s002ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/22320Orig1s002.pdf
02/18/2011	SUPPL-1	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022320s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022320s001ltr.pdf

Labels for NDA 022320

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/01/2013	SUPPL-4	Efficacy-New Patient Population	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022320s004lbl.pdf
12/14/2011	SUPPL-2	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022320s002lbl.pdf
02/18/2011	SUPPL-1	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022320s001lbl.pdf
12/08/2008	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022320lbl.pdf

Therapeutic Equivalents for NDA 022320

EPIDUO

GEL;TOPICAL; 0.1%;2.5%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ADAPALENE AND BENZOYL PEROXIDE	ADAPALENE; BENZOYL PEROXIDE	0.1%;2.5%	GEL;TOPICAL	Prescription	No	AB	206164	ENCUBE
ADAPALENE AND BENZOYL PEROXIDE	ADAPALENE; BENZOYL PEROXIDE	0.1%;2.5%	GEL;TOPICAL	Prescription	No	AB	208108	GLENMARK PHARMS LTD
ADAPALENE AND BENZOYL PEROXIDE	ADAPALENE; BENZOYL PEROXIDE	0.1%;2.5%	GEL;TOPICAL	Prescription	No	AB	205033	PADAGIS ISRAEL
ADAPALENE AND BENZOYL PEROXIDE	ADAPALENE; BENZOYL PEROXIDE	0.1%;2.5%	GEL;TOPICAL	Prescription	No	AB	206959	TARO
EPIDUO	ADAPALENE; BENZOYL PEROXIDE	0.1%;2.5%	GEL;TOPICAL	Prescription	Yes	AB	022320	GALDERMA LABS LP

Top